Standardization clinical research and mechanism discussion of of natural moxibustion acupoint application for Bronchial Asthma
- Conditions
- Bronchial Asthma
- Registration Number
- ITMCTR1900002478
- Lead Sponsor
- The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1 Patients who are diagnosed as chronic duration and clinical remission of bronchial asthma in Western medicine;
2 Patients who are diagnosed with Chinese medicine asthma lung and kidney qi deficiency syndrome;
3 The severity of the disease is classified as mildly persistent or moderately persistent;
4 Aged 18 to 75 years, both men and women;
5 Those who voluntarily receive the drug and sign the informed consent form (the informed consent process complies with the GCP requirements).
1 other diseases with airflow obstruction, such as chronic obstructive pulmonary disease, bronchiectasis, pulmonary tuberculosis, diffuse panbronchiolitis and other patients;
2 patients with severe cardiovascular and cerebrovascular diseases, liver and kidney dysfunction, upper extremity ankle amputation and hematopoietic dysfunction;
3 mental patients and those who cannot be treated for other reasons;
4 pregnant or lactating women;
5 It is known that those who are allergic to the test ingredients and the skin of the treatment site have blistering, sputum, damage and fever.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FEV1;
- Secondary Outcome Measures
Name Time Method IL-5, IL-13, IL-23, IL-25, TSLP;The Asthma Quality of Life;Metallothionein-2, Transgelin-2;Asthma control test;